Qbrelis Solution
Product Images NDC 52652-3001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Qbrelis (NDC 52652-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

Principal Display Panel (Bottle Label)

Principal Display Panel (Bottle Label)
This is a description of a medication with the identifier NDC 52652-3001-1. The medication contains lisinopril, with a concentration of 1 mg/mL in a 150 mL oral solution. The usual dose is not provided, so one must refer to the prescribing information. It is suggested to store the medication at room temperature (20°-25°C or 68°-77°F) and to keep the container tightly closed. The medication should be kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.